Main competitors
Consensus Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Objective/dr gap Nbr of analysts
- US$531.25 +12.16% 12
Average 531.25 +12.16% 12
Weighted average by Cap. 531.25 +12.16% 12
Other Pharmaceuticals